Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy. [electronic resource]
Producer: 20190111Description: 77-83 p. digitalISSN:- 1744-7682
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Immunological -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- CTLA-4 Antigen -- antagonists & inhibitors
- Cell Cycle Checkpoints -- drug effects
- Clinical Trials, Phase II as Topic
- Dacarbazine -- administration & dosage
- Drug Synergism
- Female
- Follow-Up Studies
- Humans
- Ipilimumab -- administration & dosage
- Male
- Melanoma -- drug therapy
- Middle Aged
- Neoplasm Metastasis
- Protein Kinase Inhibitors -- administration & dosage
- Randomized Controlled Trials as Topic
- Skin Neoplasms -- drug therapy
- Survival Analysis
- Thymalfasin -- administration & dosage
- Time Factors
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.